2026
article
OpenAlex
Aidan Vosooghi, Aditya Mahadevan, Jagmeet S. Arora, Theresa Farhat et autres
PURPOSE: While immune checkpoint inhibitors (ICIs) are associated with rare, acute myocarditis, their comparative impact on chronic vascular events and heart failure versus conventional chemotherapy remains ill-defined. We compared the 2-year risk of hospitalization for major adverse cardiovascular events (MACEs) after ICI …
us
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Matthew R. Moldenhauer, Aditya Mahadevan, Cameron Hom, Angie Nguyen et autres
Lynch syndrome significantly increases the risk of developing colorectal cancer (CRC) due to an inherited defect in mismatch repair (MMR). Early detection relies on the identification of pathogenic mutations in patients with a family history of cancer, but few canonical Lynch mutations …
us
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Armon Azizi, Aditya Mahadevan, Elaine Chiao, Maheswari Senthil et autres
Abstract While the overall incidence of adenocarcinomas of the stomach and esophagus (GEA) has been declining in the United States, there has been an increase in cases among those under 50. Clinical and demographic data on GEA in young patients, especially in …
us
(code pays fourni par la source)
2026
conference-abstract
OpenAlex
Matthew R. Moldenhauer, Aditya Mahadevan, Cameron Hom, Valeria Rangel et autres
Abstract Background: Lynch syndrome significantly increases the risk of developing colorectal cancer (CRC) due to an inherited defect in mismatch repair (MMR). Early detection relies on identification of pathogenic mutations in patients, but few canonical Lynch mutations exist. We describe two separate …
us
(code pays fourni par la source)
Accès ouvert
2026
preprint
OpenAlex
Akshat Pandey, Aditya Mahadevan, A. Alan Middleton, Daniel S. Fisher
At low temperatures, the classical two-dimensional random bond Ising model undergoes a frustration-driven ferromagnet-to-paramagnet transition controlled by a zero-temperature fixed point separating ferromagnet and spin glass phases. We show that this critical point can be understood through a renormalization group transformation that …
Accès ouvert
2026
preprint
OpenAlex
Akshat Pandey, Aditya Mahadevan, A. Alan Middleton, Daniel S. Fisher
At low temperatures, the classical two-dimensional random bond Ising model undergoes a frustration-driven ferromagnet-to-paramagnet transition controlled by a zero-temperature fixed point separating ferromagnet and spin glass phases. We show that this critical point can be understood through a renormalization group transformation that …
us
(code pays fourni par la source)
2025
conference-paper
OpenAlex
M. Bindhu, P. Pattunnarajam, Sabareeswari, A. N. Duraivel et autres
in, us
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Omid Yazdanpanah, Aditya Mahadevan, David Joseph Benjamin, Elham Vosoughi et autres
INTRODUCTION: Treatment of metastatic renal cell carcinoma (mRCC) has expanded with development of combination therapies containing tyrosine kinase inhibitors (TKIs) with immune checkpoint inhibitors (ICI) agents or dual ICI agents. However, patient preferences may not necessarily be incorporated into management decisions. We …
us
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Frank Lee, Aditya Mahadevan, Armon Azizi, Jennifer Valerin et autres
BACKGROUND: Ensuring that clinical trial enrollment reflects the demographics and disease burden of a cancer center's catchment area is essential for improving trial accrual and the generalizability of research findings. We hypothesized that aligning the clinical trial portfolio with the needs of …
us
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Jagmeet S. Arora, Aditya Mahadevan, Janellen Smith, Michelle S. Min
us
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Kara Banson, Matthew E Schelin, Jason Gurewitz, Kenneth Bernstein et autres
2025
article
OpenAlex
Aditya Mahadevan, Armon Azizi, Nadine Abi‐Jaoudeh, Jennifer Valerin et autres
Treatment options for hepatocellular carcinoma (HCC), the most prevalent primary liver malignancy, have historically been limited, particularly in unresectable cases with underlying cirrhosis. Initial systemic therapy with antiangiogenic agents, notably vascular endothelial growth factor (VEGF) inhibitors such as sorafenib, showed modest survival …
us
(code pays fourni par la source)